Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer

The usefulness of serum CYFRA 21-1 (cytokeratin-19 fragments) in monitoring the recurrence of breast cancer and in evaluating therapeutic effects was studied retrospectively. The sera from 173 patients with primary breast cancer or recurrent disease were measured for CYFRA 21-1, carcinoembryonic ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakata, B, Takashima, T, Ogawa, Y, Ishikawa, T, Hirakawa, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409884/
https://www.ncbi.nlm.nih.gov/pubmed/15280913
http://dx.doi.org/10.1038/sj.bjc.6602074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409884/
https://www.ncbi.nlm.nih.gov/pubmed/15280913
http://dx.doi.org/10.1038/sj.bjc.6602074

Ejemplares similares